Latest from John Theurer Cancer Center

Andre Goy, MD, discusses the recent success with CAR T-cell therapy, and what is on the horizon for this therapeutic option across hematologic malignancies.
Trials evaluate combined immunotherapy with stem cell transplant to combat hematologic malignancies.
A group of researchers from several institutions in the US, including John Theurer Cancer Center, studied the development of a new, web-based intervention - Pep-Pal- to provide psychoeducation and skills for caregivers of cancer patients who are experiencing significant burden and distress including depression and anxiety.
John Theurer Cancer Center Oncology Nurses recently attended the 42nd Annual National Oncology Nursing Society’s (ONS) conference "Congress" in Denver, Colorado.  Nurses in attendance presented projects they have been involved with in their area of expertise to the largest group of oncology nurses worldwide.
Watson for Oncology combined with real world data from Cota aims to help oncologists improve cancer treatment and reduce costs.
MedStar Georgetown University Hospital in Washington, D.C. in collaboration with John Theurer Cancer Center, part of Hackensack Meridian Health,  Hackensack University Medical Center in Hackensack, N.J., announce the 100th blood stem cell transplant performed since the BMT program’s first patient was treated in September, 2013.
Andre Goy, MD, MS, chairman and director, chief of Lymphoma, and director of Clinical and Translational Cancer Research at John Theurer Cancer Center, discusses the efficacy of lenalidomide (Revlimid) for the treatment of patients with mantle cell lymphoma (MCL).
Publication Bottom Border
Border Publication